<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Briefs</title>
    <description></description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Biopharma money raised: Jan. 1-July 9, 2026</title>
      <description>Year-to-date money raised in public, private and other financings of biopharma companies.</description>
      <content:encoded>
        <![CDATA[Year-to-date money raised in public, private and other financings of biopharma companies.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732623</guid>
      <pubDate>Fri, 10 Jul 2026 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732623-biopharma-money-raised-jan-1-july-9-2026</link>
    </item>
    <item>
      <title>Money raised by biopharma</title>
      <description>Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.</description>
      <content:encoded>
        <![CDATA[Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732622</guid>
      <pubDate>Fri, 10 Jul 2026 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732622-money-raised-by-biopharma</link>
    </item>
    <item>
      <title>Regulatory actions for July 10, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord, Arialys, Ihealth, Intas, Natera, Octapharma, Roche.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord, Arialys, Ihealth, Intas, Natera, Octapharma, Roche.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732541</guid>
      <pubDate>Fri, 10 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732541-regulatory-actions-for-july-10-2026</link>
    </item>
    <item>
      <title>Other news to note for July 10, 2026</title>
      <description>Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Accurkardia, Adneuris, Atsena, Biomedx, Boehringer, Envue, FBD, Hanchorbio, Inxmed, Irenix, Neogenomics, Polpharma, Proteina, Robocath, Samsung, Stereotaxis, Tarsus, Teva, Wellysis.</description>
      <content:encoded>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Accurkardia, Adneuris, Atsena, Biomedx, Boehringer, Envue, FBD, Hanchorbio, Inxmed, Irenix, Neogenomics, Polpharma, Proteina, Robocath, Samsung, Stereotaxis, Tarsus, Teva, Wellysis.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732540</guid>
      <pubDate>Fri, 10 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732540-other-news-to-note-for-july-10-2026</link>
    </item>
    <item>
      <title>In the clinic for July 10, 2026</title>
      <description>Clinical updates for biopharma and med tech, including data readouts and publications: Astrazeneca, Betta, Biocon, Forte, In8bio, Inxmed, Ionis, Ipsen, Northwest, Rhythm.</description>
      <content:encoded>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Astrazeneca, Betta, Biocon, Forte, In8bio, Inxmed, Ionis, Ipsen, Northwest, Rhythm.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732539</guid>
      <pubDate>Fri, 10 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732539-in-the-clinic-for-july-10-2026</link>
    </item>
    <item>
      <title>Financings for July 10, 2026</title>
      <description>Biopharma and med-tech companies raising money in public or private financings, including: Alchemab, Amprion.</description>
      <content:encoded>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Alchemab, Amprion.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732538</guid>
      <pubDate>Fri, 10 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732538-financings-for-july-10-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for July 10, 2026</title>
      <description>New hires and promotions in the biopharma and med-tech industries, including: Betterlife, Clearnote, Fibrobiologics, Foresee, GSK, Latigo, Spinogenix, Takara, Vera.</description>
      <content:encoded>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Betterlife, Clearnote, Fibrobiologics, Foresee, GSK, Latigo, Spinogenix, Takara, Vera.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732537</guid>
      <pubDate>Fri, 10 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732537-appointments-and-advancements-for-july-10-2026</link>
    </item>
    <item>
      <title>Today's news in brief</title>
      <description>BioWorld briefs for July 10, 2026.</description>
      <content:encoded>
        <![CDATA[BioWorld briefs for July 10, 2026.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/432891</guid>
      <pubDate>Fri, 10 Jul 2026 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/432891-todays-news-in-brief</link>
    </item>
    <item>
      <title>Regulatory actions for July 9, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arcutis, Grünenthal, Immunome, J&amp;J, Merck, OS, Vanda, Vera.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arcutis, Grünenthal, Immunome, J&J, Merck, OS, Vanda, Vera.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732527</guid>
      <pubDate>Thu, 09 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732527-regulatory-actions-for-july-9-2026</link>
    </item>
    <item>
      <title>Other news to note for July 9, 2026</title>
      <description>Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Alector, Amgen, Beam, Chemomab, Everest, Fosun, GSK, LG, Niagen, Octave, OTR, Prime, Resmed, Scipher, Travere, Virax.</description>
      <content:encoded>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Alector, Amgen, Beam, Chemomab, Everest, Fosun, GSK, LG, Niagen, Octave, OTR, Prime, Resmed, Scipher, Travere, Virax.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732526</guid>
      <pubDate>Thu, 09 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732526-other-news-to-note-for-july-9-2026</link>
    </item>
    <item>
      <title>In the clinic for July 9, 2026</title>
      <description>Clinical updates for biopharma and med tech, including data readouts and publications: Keenova, Maia, Satellos, Seres.</description>
      <content:encoded>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Keenova, Maia, Satellos, Seres.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732525</guid>
      <pubDate>Thu, 09 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732525-in-the-clinic-for-july-9-2026</link>
    </item>
    <item>
      <title>Financings for July 9, 2026</title>
      <description>Biopharma and med-tech companies raising money in public or private financings, including: Allotera, Bone Biologics, Leo Cancer, Lifeward, Oramed.</description>
      <content:encoded>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Allotera, Bone Biologics, Leo Cancer, Lifeward, Oramed.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732524</guid>
      <pubDate>Thu, 09 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732524-financings-for-july-9-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for July 9, 2026</title>
      <description>New hires and promotions in the biopharma and med-tech industries, including: ARS, Aura, Avacta, Moderna, Newcelx, Ovid, Tensive, Tolion, Upfront, Vor, Whoop.</description>
      <content:encoded>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: ARS, Aura, Avacta, Moderna, Newcelx, Ovid, Tensive, Tolion, Upfront, Vor, Whoop.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732523</guid>
      <pubDate>Thu, 09 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732523-appointments-and-advancements-for-july-9-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 8, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Beckman, Emmecell, Genmab, Movmedix, Organogenesis, Revolution, Saol.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Beckman, Emmecell, Genmab, Movmedix, Organogenesis, Revolution, Saol.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732443</guid>
      <pubDate>Wed, 08 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732443-regulatory-actions-for-july-8-2026</link>
    </item>
    <item>
      <title>Other news to note for July 8, 2026</title>
      <description>Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Alamar, Alcon, Bio-Rad, Biocartis, Biocytogen, Cresilon, Corza, Discovery, Ethos, GTCR, Incite Genomics, Novo Nordisk, Praxis, Remagine, Rxsight, Vivani, Whitehawk, Xeltis.</description>
      <content:encoded>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Alamar, Alcon, Bio-Rad, Biocartis, Biocytogen, Cresilon, Corza, Discovery, Ethos, GTCR, Incite Genomics, Novo Nordisk, Praxis, Remagine, Rxsight, Vivani, Whitehawk, Xeltis.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732442</guid>
      <pubDate>Wed, 08 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732442-other-news-to-note-for-july-8-2026</link>
    </item>
    <item>
      <title>In the clinic for July 8, 2026</title>
      <description>Clinical updates for biopharma and med tech, including data readouts and publications: Compass, HMNC, Italfarmaco, ITM, Kailera, Oncotelic, Teva, Turn, Tvardi, Vaxart, Volitionrx.</description>
      <content:encoded>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Compass, HMNC, Italfarmaco, ITM, Kailera, Oncotelic, Teva, Turn, Tvardi, Vaxart, Volitionrx.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732441</guid>
      <pubDate>Wed, 08 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732441-in-the-clinic-for-july-8-2026</link>
    </item>
    <item>
      <title>Financings for July 8, 2026</title>
      <description>Biopharma and med-tech companies raising money in public or private financings, including: Fore, Healome, Kalohexis, Semnur.</description>
      <content:encoded>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Fore, Healome, Kalohexis, Semnur.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732440</guid>
      <pubDate>Wed, 08 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732440-financings-for-july-8-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for July 8, 2026</title>
      <description>New hires and promotions in the biopharma and med-tech industries, including: Akari, Amplia, Biovica, Demerx, Eupraxia, Imagenebio, Jupiter, Kymera, Levicept, Longeveron, Paradromics, Stipple, Uniquity, Vascular Perfusion Solutions.</description>
      <content:encoded>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Akari, Amplia, Biovica, Demerx, Eupraxia, Imagenebio, Jupiter, Kymera, Levicept, Longeveron, Paradromics, Stipple, Uniquity, Vascular Perfusion Solutions.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732439</guid>
      <pubDate>Wed, 08 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732439-appointments-and-advancements-for-july-8-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 7, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Ascelia, Forus, Invivyd, Median, Pharmaessentia, Pharvaris, Visby.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Ascelia, Forus, Invivyd, Median, Pharmaessentia, Pharvaris, Visby.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732429</guid>
      <pubDate>Tue, 07 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732429-regulatory-actions-for-july-7-2026</link>
    </item>
    <item>
      <title>Other news to note for July 7, 2026</title>
      <description>Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Astex, Baiyunshan, Genentech, Incyte, Natera, Roche, Sanyou, Star, Tempramed, Vega.</description>
      <content:encoded>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Astex, Baiyunshan, Genentech, Incyte, Natera, Roche, Sanyou, Star, Tempramed, Vega.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732428</guid>
      <pubDate>Tue, 07 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732428-other-news-to-note-for-july-7-2026</link>
    </item>
    <item>
      <title>In the clinic for July 7, 2026</title>
      <description>Clinical updates for biopharma and med tech, including data readouts and publications: Agenus, Anixa, Brii.</description>
      <content:encoded>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Agenus, Anixa, Brii.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732427</guid>
      <pubDate>Tue, 07 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732427-in-the-clinic-for-july-7-2026</link>
    </item>
    <item>
      <title>Financings for July 7, 2026</title>
      <description>Biopharma and med-tech companies raising money in public or private financings, including: Scribe.</description>
      <content:encoded>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Scribe.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732426</guid>
      <pubDate>Tue, 07 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732426-financings-for-july-7-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for July 7, 2026</title>
      <description>New hires and promotions in the biopharma and med-tech industries, including: Abcellera, Acadia, Capsovision, Corbus, Vicore.</description>
      <content:encoded>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Abcellera, Acadia, Capsovision, Corbus, Vicore.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732425</guid>
      <pubDate>Tue, 07 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732425-appointments-and-advancements-for-july-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 7, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Cansino, Daiichi Sankyo, Eisai, Hengrui, Hutchmed, Kowa, Novaliq, Nuvation.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Cansino, Daiichi Sankyo, Eisai, Hengrui, Hutchmed, Kowa, Novaliq, Nuvation.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732449</guid>
      <pubDate>Tue, 07 Jul 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732449-regulatory-actions-for-july-7-2026</link>
    </item>
    <item>
      <title>Other news to note for July 7, 2026</title>
      <description>Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: Abbisko, Aimedbio, ALR Technologies, Aptose, Astrazeneca, Ayumi, Best Praise, CSPC, Eli Lilly, Fosun Wanbang, GNI, Hanmi, Innovent, Inocras, Insilico Medicine, Junshi, Kyowa Kirin, Orion, Shilpa Biologicals, SK Bioscience, Takeda, Universe.</description>
      <content:encoded>
        <![CDATA[Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: Abbisko, Aimedbio, ALR Technologies, Aptose, Astrazeneca, Ayumi, Best Praise, CSPC, Eli Lilly, Fosun Wanbang, GNI, Hanmi, Innovent, Inocras, Insilico Medicine, Junshi, Kyowa Kirin, Orion, Shilpa Biologicals, SK Bioscience, Takeda, Universe.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732448</guid>
      <pubDate>Tue, 07 Jul 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732448-other-news-to-note-for-july-7-2026</link>
    </item>
    <item>
      <title>In the clinic for July 7, 2026</title>
      <description>Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Avecho, Otsuka, Samsung.</description>
      <content:encoded>
        <![CDATA[Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Avecho, Otsuka, Samsung.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732447</guid>
      <pubDate>Tue, 07 Jul 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732447-in-the-clinic-for-july-7-2026</link>
    </item>
    <item>
      <title>Financings for July 7, 2026</title>
      <description>Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: Biobot Surgical.</description>
      <content:encoded>
        <![CDATA[Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: Biobot Surgical.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732446</guid>
      <pubDate>Tue, 07 Jul 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732446-financings-for-july-7-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for July 7, 2026</title>
      <description>New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Peptidream.</description>
      <content:encoded>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Peptidream.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732445</guid>
      <pubDate>Tue, 07 Jul 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732445-appointments-and-advancements-for-july-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 6, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Hutchmed, Novartis, Polaritybio, Tenon, Vertex.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Hutchmed, Novartis, Polaritybio, Tenon, Vertex.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732301</guid>
      <pubDate>Mon, 06 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732301-regulatory-actions-for-july-6-2026</link>
    </item>
    <item>
      <title>Other news to note for July 6, 2026</title>
      <description>Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Abbisko, Astrazeneca, Ayumi, Bridgebio, Caredx, Clearone, Cortigent, Fosun, GNI, Insilico, Junshi, Lonza, Naveris, Nona, SK, Takeda, Thymmune, United, Vivani.</description>
      <content:encoded>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Abbisko, Astrazeneca, Ayumi, Bridgebio, Caredx, Clearone, Cortigent, Fosun, GNI, Insilico, Junshi, Lonza, Naveris, Nona, SK, Takeda, Thymmune, United, Vivani.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732300</guid>
      <pubDate>Mon, 06 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732300-other-news-to-note-for-july-6-2026</link>
    </item>
  </channel>
</rss>
